Mackillop LH, Germain SJ, Nelson-Piercy C. Systemic lupus erythematosus. BMJ. 2007;335:933–6.

Article  PubMed  PubMed Central  Google Scholar 

Kiriakidou M, Ching CL. Systemic lupus erythematosus. Ann Intern Med. 2020;172:Itc81–96.

Article  PubMed  Google Scholar 

Smith EMD, Lythgoe H, Midgley A, Beresford MW, Hedrich CM. Juvenile-onset systemic lupus erythematosus: update on clinical presentation, pathophysiology and treatment options. Clin Immunol (Orlando, Fla). 2019;209: 108274.

Article  CAS  Google Scholar 

Charras A, Smith E, Hedrich CM. Systemic lupus erythematosus in children and young people. Curr Rheumatol Rep. 2021;23:20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hiraki LT, Feldman CH, Liu J, Alarcón GS, Fischer MA, Winkelmayer WC, Costenbader KH. Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population. Arthritis Rheum. 2012;64:2669–76.

Article  PubMed  PubMed Central  Google Scholar 

Pineles D, Valente A, Warren B, Peterson MG, Lehman TJ, Moorthy LN. Worldwide incidence and prevalence of pediatric onset systemic lupus erythematosus. Lupus. 2011;20:1187–92.

Article  CAS  PubMed  Google Scholar 

Gao S, Yu Z, Ma X, Sun J, Ren A, Gao S, Gong M, Zhou X, Ma M, Song H. Childhood-onset systemic lupus erythematosus in China, 2016–21: a nationwide study. Lancet Child Adolesc Health. 2024;8:762–72.

Article  PubMed  Google Scholar 

Kamphuis S, Silverman ED. Prevalence and burden of pediatric-onset systemic lupus erythematosus. Nat Rev Rheumatol. 2010;6:538–46.

Article  CAS  PubMed  Google Scholar 

Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011;365:2110–21.

Article  CAS  PubMed  Google Scholar 

Zhu J, Wu F, Huang X. Age-related differences in the clinical characteristics of systemic lupus erythematosus in children. Rheumatol Int. 2013;33:111–5.

Article  CAS  PubMed  Google Scholar 

Hou Y, Wang L, Luo C, Tang W, Dai R, An Y, Tang X. Clinical characteristics of early-onset paediatric systemic lupus erythematosus in a single centre in China. Rheumatology (Oxford). 2023;62:3373–81.

Article  CAS  PubMed  Google Scholar 

Vasquez-Canizares N, Wahezi D, Putterman C. Diagnostic and prognostic tests in systemic lupus erythematosus. Best Pract Res Clin Rheumatol. 2017;31:351–63.

Article  PubMed  PubMed Central  Google Scholar 

Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.

Article  CAS  PubMed  Google Scholar 

Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR, Bruce IN, Isenberg D, Wallace DJ, Nived O, Sturfelt G, Ramsey-Goldman R, Bae SC, Hanly JG, Sánchez-Guerrero J, Clarke A, Aranow C, Manzi S, Urowitz M, Gladman D, Kalunian K, Costner M, Werth VP, Zoma A, Bernatsky S, Ruiz-Irastorza G, Khamashta MA, Jacobsen S, Buyon JP, Maddison P, Dooley MA, van Vollenhoven RF, Ginzler E, Stoll T, Peschken C, Jorizzo JL, Callen JP, Lim SS, Fessler BJ, Inanc M, Kamen DL, Rahman A, Steinsson K, Franks AG Jr, Sigler L, Hameed S, Fang H, Pham N, Brey R, Weisman MH, McGwin G Jr, Magder LS. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64:2677–86.

Article  PubMed  PubMed Central  Google Scholar 

Groot N, de Graeff N, Marks SD, Brogan P, Avcin T, Bader-Meunier B, Dolezalova P, Feldman BM, Kone-Paut I, Lahdenne P, McCann L, Özen S, Pilkington CA, Ravelli A, Royen-Kerkhof AV, Uziel Y, Vastert BJ, Wulffraat NM, Beresford MW, Kamphuis S. European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative. Ann Rheum Dis. 2017;76:1965–73.

Article  CAS  PubMed  Google Scholar 

Cody EM, Brunner HI. Biomarkers in childhood-onset systemic lupus erythematosus. Rheum Dis Clin North Am. 2022;48:271–85.

Article  PubMed  Google Scholar 

Yu H, Nagafuchi Y, Fujio K. Clinical and immunological biomarkers for systemic lupus erythematosus. Biomolecules. 2021. https://doi.org/10.3390/biom11070928.

Article  PubMed  PubMed Central  Google Scholar 

Ayano M, Horiuchi T. Complement as a biomarker for systemic lupus erythematosus. Biomolecules. 2023. https://doi.org/10.3390/biom13020367.

Article  PubMed  PubMed Central  Google Scholar 

Lu R, Munroe ME, Guthridge JM, Bean KM, Fife DA, Chen H, Slight-Webb SR, Keith MP, Harley JB, James JA. Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies. J Autoimmun. 2016;74:182–93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Melamud MM, Ermakov EA, Boiko AS, Kamaeva DA, Sizikov AE, Ivanova SA, Baulina NM, Favorova OO, Nevinsky GA, Buneva VN. Multiplex analysis of serum cytokine profiles in systemic lupus erythematosus and multiple sclerosis. Int J Mol Sci. 2022. https://doi.org/10.3390/ijms232213829.

Article  PubMed  PubMed Central  Google Scholar 

Arnaud L, Chasset F, Martin T. Immunopathogenesis of systemic lupus erythematosus: an update. Autoimmun Rev. 2024;23: 103648.

Article  CAS  PubMed  Google Scholar 

Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med. 2006;354:610–21.

Article  CAS  PubMed  Google Scholar 

Zlotnik A, Yoshie O. The chemokine superfamily revisited. Immunity. 2012;36:705–16.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Duan L, Yao Y, Kong H, Zhou Y, Cui D. Chemokines and chemokine receptors: potential therapeutic targets in systemic lupus erythematosus. Cytokine. 2024;184: 156770.

Article  CAS  PubMed  Google Scholar 

Bonecchi R, Sozzani S, Stine JT, Luini W, D’Amico G, Allavena P, Chantry D, Mantovani A. Divergent effects of interleukin-4 and interferon-gamma on macrophage-derived chemokine production: an amplification circuit of polarized T helper 2 responses. Blood. 1998;92:2668–71.

Article  CAS  PubMed  Google Scholar 

Yamashita U, Kuroda E. Regulation of macrophage-derived chemokine (MDC, CCL22) production. Crit Rev Immunol. 2002;22:105–14.

Article  CAS  PubMed  Google Scholar 

Yoshie O, Matsushima K. CCR4 and its ligands: from bench to bedside. Int Immunol. 2015;27:11–20.

Article  CAS  PubMed  Google Scholar 

Rapp M, Wintergerst MWM, Kunz WG, Vetter VK, Knott MML, Lisowski D, Haubner S, Moder S, Thaler R, Eiber S, Meyer B, Röhrle N, Piseddu I, Grassmann S, Layritz P, Kühnemuth B, Stutte S, Bourquin C, von Andrian UH, Endres S, Anz D. CCL22 controls immunity by promoting regulatory T cell communication with dendritic cells in lymph nodes. J Exp Med. 2019;216:1170–81.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xiao ZF, Zou SS, Yi CF, Zhao Y, Wu LS, Feng YH. Expression and clinical significance of CCL17, CCL22, and CCR4 in newly diagnosed multiple myeloma. Zhonghua Xue Ye Xue Za Zhi Zhonghua Xueyexue Zazhi. 2024;45:672–7.

CAS  PubMed  Google Scholar 

Melgrati S, Radice E, Ameti R, Hub E, Thelen S, Pelczar P, Jarrossay D, Rot A, Thelen M. Atlas of the anatomical localization of atypical chemokine receptors in healthy mice. PLoS Biol. 2023;21: e3002111.

Article  CAS